Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Startup Stratos Genomics Raises $4M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stratos Genomics today announced that it has raised $4 million through a Series A financing led by Fisk Ventures and including Stratos Group LLC.

The Seattle-based firm said that it would use the proceeds to continue developing its ultra-low-cost nucleic acid sequencing method for whole-genome analysis and molecular diagnostic applications. Stratos Genomics, which is a spinoff of Stratos Group, has developed a single-molecule sequencing method called "sequencing by expansion."

"The Stratos Genomics technology has the potential to revolutionize personalized medicine and bring genome sequencing technology to all," Stephen Rose, Managing Director of Fisk Ventures, said. "If our goals are realized, Stratos Genomics will have a huge impact on life sciences."

Following the investment, Rose has joined the board of directors of Stratos Genomics.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.